MATTHEW W FOEHR Insider Trading
Get free email notifications about insider trading for MATTHEW W FOEHR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW W FOEHR. MATTHEW W FOEHR is a President and COO in LIGAND PHARMACEUTICALS INC ($LGND) and a Sr. VP Technical Operations in CONNETICS CORP ($CNCT) and a Director in RITTER PHARMACEUTICALS INC ($RTTR) and a Director in Viking Therapeutics, Inc. ($VKTX).
Address: 3290 WEST BAYSHORE ROAD PALO ALTO 94303 CA
Companies in which MATTHEW W FOEHR is an Insider
CONNETICS CORP
Trading Symbol: CNCTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: Sr. VP Technical Operations
Holdings: 7,331 shares
Current Value: $0
Latest Transaction: Apr 20 2005
$CNCT Market Capitalization: $389378.34
$CNCT Previous Close: $0.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LIGAND PHARMACEUTICALS INC
Trading Symbol: LGNDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: President and COO
Holdings: 167,198 shares
Current Value: $18,030,632
Latest Transaction: Feb 05 2021
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Qualigen Therapeutics, Inc.
Trading Symbol: RTTRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: Director
Holdings: 100,174 shares
Current Value: $344,599
Latest Transaction: Apr 23 2020
$RTTR Market Capitalization: $36.80M
$RTTR Previous Close: $3.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viking Therapeutics, Inc.
Trading Symbol: VKTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: Director
Holdings: 46,250 shares
Current Value: $67,063
Latest Transaction: Mar 25 2021
$VKTX Market Capitalization: $31.36M
$VKTX Previous Close: $1.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MATTHEW W FOEHR
Sentiment: All, CNCT, LGND, RTTR, VKTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | X | 1.50 | 20,000 | 30,000 | 0 | |
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | X | 1.50 | 20,000 | 30,000 | 46,250 | 26.3 K to 46.3 K (+76.19 %) |
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | X | 1.50 | 20,000 | 30,000 | 0 | |
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | X | 1.50 | 20,000 | 30,000 | 46,250 | 26.3 K to 46.3 K (+76.19 %) |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | A | 177.50 | 13,136 | 2,331,640 | 13,136 | |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 74.42 | 1,000 | 74,420 | 63,210 | |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 44,547 | 976,470 | 20,000 |